How Can the NCCN Guidelines for Patients®: Myeloproliferative Neoplasms (MPNs) Help You Make More Informed Decisions?
If you or a loved one have been diagnosed with an MPN, you may want to consult an educational resource from MPN experts. One such resource is called the NCCN Guidelines for Patients: Myeloproliferative Neoplasms.
These Guidelines can help empower patients living with MPNs—a group of rare, chronic blood cancers—to become their own advocates in working with their Healthcare Professional(s). The Guidelines focus on the three classic types of MPNs: polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF).
What Should You Know About the NCCN Guidelines for Patients: Myeloproliferative Neoplasms?
The NCCN Guidelines for Patients: Myeloproliferative Neoplasms are meant to help you talk with your Healthcare Professional so together you can work to achieve the best possible outcome for you and your individual circumstances.
The patient-friendly information, illustrations, and suggested questions for medical appointments included in the Guidelines can help you more clearly understand the best practices available in managing your PV, ET, or MF. By reading the expert Guidelines, you can feel more knowledgeable when you talk with your Healthcare Professional about making decisions that are right for you.
What Should You Know About the National Comprehensive Cancer Network® (NCCN®)?
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 30 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives.
At the core of the NCCN are the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Healthcare Professionals, which contain information to help healthcare workers plan the best cancer care.
Living every day to the fullest knowing all the great people working hard on our behalf to enable us to do so! –JoAnn, MPN community member
The NCCN Guidelines for Patients are for people with cancer and those who support them. They are based on the NCCN Guidelines and list the same cancer care options.
The NCCN Guidelines for Patients: Myeloproliferative Neoplasms are sponsored by the MPN Research Foundation. They are endorsed by The Leukemia & Lymphoma Society, MPN Cancer Connection, and the MPN Education Foundation.
How Can You Access the NCCN Guidelines for Patients: Myeloproliferative Neoplasms?
VIEW THE NCCN GUIDELINES FOR PATIENTS: A COMPREHENSIVE RESOURCE FOR PEOPLE LIVING WITH MPNsVIEW GUIDELINES
The NCCN Guidelines for Patients: Myeloproliferative Neoplasms are readily accessible online. Whether you're searching for information about PV, ET, or MF, you'll find expert advice that may have a positive impact on how you and your Healthcare Professional manage your MPN.